This resolution expresses support for the recognition of "Hidradenitis Suppurativa Awareness Week" , aiming to raise public and professional awareness about this chronic, inflammatory skin disease. It highlights that Hidradenitis Suppurativa (HS) affects millions, causes significant physical and emotional suffering, and is often misdiagnosed, leading to delayed intervention and worsening progression. The resolution underscores the importance of increasing education, promoting timely and accurate diagnosis through better screening and culturally competent care, and supporting biomedical research into HS pathogenesis and treatment efficacy. Furthermore, it calls for accelerating the development of new treatments and expanding access to existing therapies. Finally, it advocates for advancing policies that address disparities in care access and improve the overall quality of life for individuals living with HS and their caregivers.